Browse > Article

Proteomic Analysis of Rat PC12 Cells Exposed to Cyclosporin A  

Jung, Ji-Yeon (Department of Oral Physiology, Dental Science Research Institute, Brain Korea 21 Project, School of Dentistry Chonnam National University)
Seol, Kwang (Department of Oral Physiology, Dental Science Research Institute, Brain Korea 21 Project, School of Dentistry Chonnam National University)
Jeong, Yeon-Jin (Department of Oral Physiology, Dental Science Research Institute, Brain Korea 21 Project, School of Dentistry Chonnam National University)
Kim, Won-Jae (Department of Oral Physiology, Dental Science Research Institute, Brain Korea 21 Project, School of Dentistry Chonnam National University)
Oh, Sang-Jin (School of Biological Sciences and Technology, Chonnam National University)
Publication Information
International Journal of Oral Biology / v.34, no.1, 2009 , pp. 29-36 More about this Journal
Abstract
Cyclosporin A (CsA) has been used clinically as an immunosuppressive drug to prevent organ transplant rejection and in basic research as a mitochondrial permeability blocker. It has been reported that CsA has a protective role in severed neurons and a neurotrophic effect in neuronal cells. However, the molecular mechanisms underlying the stimulation of neuronal cell proliferation by CsA have not yet been elucidated. In our current study, we investigated CsA responsive proteins in PC12 cells using a systematic proteomic approach. The viability of these cells following CsA treatment increased in a dose- and time-dependent manner. Proteins in the CsA-treated PC12 cells were profiled by two-dimensional gel electrophoresis (2-DE) and identified by matrix-assisted laser desorption ionization time-of flight (MALDI-TOF) and electrospray ionization quadupole time-of-flight mass spectrometries (EIQ-TOFMS). This differential expression analysis showed significant changes for 10 proteins (6 up-regulated and 4 down-regulated) upon CsA treatment that were related to cell proliferation, metabolism and the stress response. These proteomics data further our understanding of the proliferation mechanisms of PC12 cells exposed to CsA and demonstrate that our methodology has potential to further elucidate the mechanisms and pathways involved.
Keywords
Proteomics; PC12 cells; Cyclosporin A; Proliferation;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Hoffmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem. 2002;383:347-64   DOI   ScienceOn
2 Li F, Zhang D, Fujise K. Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem. 2001;276:47542-9   DOI   ScienceOn
3 Prosperi MT, Ferbus D, Rouillard D, Goubin G. The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett. 1998;423:39-44   DOI   ScienceOn
4 Yenofsky R, Cereghini S, Krowczynska A, Brawerman G. Regulation of mRNA utilization in mouse erythroleukemia cells induced to differentiate by exposure to dimethyl sulfoxide. Mol Cell Biol. 1983;3:1197-203   PUBMED
5 Scheler C, Lamer S, Pan Z, Li XP, Salinikow J, Jungblut P. Peptide mass fingerprint sequence coverage from differently stained proteins on two-dimensional electrophoresis patterns by matrix assisted laser desorption/ionization-mass spectrometry (MALDI-MS). Electrophoresis. 1998;19:918-27   DOI   ScienceOn
6 Park JI; Lee GS; Jeong YJ; Kim BK; Kim JH; Lim HS; Kim SH; Kim WJ; Jung JY. Involvement of Antiapoptotic Signals in Rat PC12 Cells Proliferation by Cyclosporin A Treatment. Int J of Oral Biol. 2007;32:51-7
7 Hellman U, Wernstedt C, Gonez J, Heldin CH. Improvement of an "In-Gel" disgestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal Biochem. 1995;224:451-5   DOI   PUBMED   ScienceOn
8 Moore MS, Blobel G. Purification of a Ran-interacting protein that is required for protein import into the nucleus. Proc Natl Acad Sci USA. 1994;91:10212-6   DOI   ScienceOn
9 Hartl FU. Molecular chaperones in cellular protein folding. Nature. 1996;381:571-9   DOI   PUBMED   ScienceOn
10 Quimby BB, Leung SW, Bayliss R, Harreman MT, Thirumala G, Stewart M, Corbett AH. Functional analysis of the hydrophobic patch on nuclear transport factor 2 involved in interactions with the nuclear pore in vivo. J Biol Chem. 2001;276:38820-9   DOI   ScienceOn
11 Faulds D, Goa KL, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 1993;45:953-1040   DOI   ScienceOn
12 Coley C, Jarvis K, Hassell T. Effect of cyclosporin-A on human gingival fibroblasts in vitro. J Dent Res. 1986;65:353-8
13 Leprince P, Rogister B, Delree P, Rigo JM, Andre' B, Moonen G. Modulation of proteolytic activity during neuritogenesis in the PC12 nerve cell: differential control of plasminogen activator and plasminogen activator inhibitor activities by nerve growth factor and dibutyryl-cyclic AMP. J Neurochem. 1991;57:665-74   DOI   PUBMED
14 Grabowski DT, Deutsch WA, Derda D, Kelley MR. Drosophila AP3, a presumptive DNA repair protein, is homologous to human ribosomal associated protein PO. Nucleic Acids Res. 1991;19:4297   DOI   ScienceOn
15 Sanchez JC, Schaller D, Ravier F, Golaz O, Jaccoud S, Belet M, Wilkins MR, James R, Deshusses J, Hochstrasser D. Translationally controlled tumor protein: A protein identified in several nontumoral cells including erythrocytes. Electrophoresis. 1997;18:150-5   DOI   ScienceOn
16 Thomas G. Translational control of mRNA expression during the early mitogenic response in Swiss mouse 3T3 cells: Identification of specific proteins. J Cell Biol. 1986;103:2137-44   DOI   ScienceOn
17 Noga M, Hayashi T, Tanaka J. Gene expressions of ubiquitin and hsp70 following focal ischemia in rat brain. Neuroreport 1997;24:1239-41
18 Sandoval JA, Hoelz DJ, Woodruff HA, Powell RL, Jay CL, Grosfeld JL, Hickeyd RJ, Malkas LH. Novel peptides secreted from human neuroblastoma: useful clinical tools? J Pediatr Surg. 2006;41:45-51   DOI   ScienceOn
19 Uchino H, Elmer E, Uchino K, Lindvall O, Siesjo BK. A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischemia in the rat. Acta Physiol Scand. 1995;155:469-71   DOI   ScienceOn
20 Zhang P, Liu B, Kang SW, Seo MS, Phee SG, Obeid LM. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem. 1997;272:30615-8   DOI   ScienceOn
21 Arcuri F, Papa S, Carducci A, Romagnoli R, Liberatori S, Riparbelli MG, Sanchez JC, Tosi P, del Vecchio MT. Translationally controlled tumor protein(TCTP) in the human prostate and prostate cancer cells: expression, distribution, and calcium binding activity. Prostate. 2004;60:130-40   DOI   ScienceOn
22 Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabo I, Zoratti M. Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J Biol Chem. 1994;267:2934-9
23 Folbergrova J, Li PA, Uchino H, Smith ML, Siesjo BK. Changes in the bioenergetic state of rat hippocampus during 2.5min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects. Exp Brain Res. 1997;114:44-50   DOI   ScienceOn
24 Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-$\alpha$. J Biol Chem. 1998;273:6297-302   DOI   ScienceOn
25 Andre N, Roquelaure B, Conrath J. Molecular effects of cyclosporin and oncogenesis: a new model. Med Hypotheses. 2004;63:647-52   DOI   ScienceOn
26 Takahashi T, Kamimura A. Cyclosporin a promotes hair epithelial cell proliferation and modulates protein kinase C expression and translocation in hair epithelial cells. J Invest Dermatol. 2001;117:605-11   DOI   ScienceOn
27 Mascarell L, Auger R, Alcover A, Ojcius DM, Jungas T, Cadet-Daniel V, Kanellopoulos JM, Truffa-Bachi P. Characterization of a gene encoding two isoforms of a mitochondrial protein up-regulated by cyclosporin A in activated T cells. J Biol Chem. 2004;279:10556-63   DOI   ScienceOn
28 Shiga Y, Onodera H, Matsuo Y, Kogure K. Cyclosporin A protects against ischemia-reperfusion injury in the brain. Brain Res. 1992;595:145-8   DOI   ScienceOn
29 Brockstedt E, Rickers A, Kostka S, Laubersheimer A, Dorken B, Wittmann-Liebold B, Bommert K, Otto A. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3. J Biol Chem. 1998;273:28057-64   DOI   ScienceOn
30 Tanaka K, Ogawa N. Immunophilin ligands: from immunosuppressants to neuroprotective drugs. Nihon Shinkei Seishin Yakurigaku Zasshi. 2004;24:71-4   PUBMED
31 Lyons WE, George EB, Dawson TM, Steiner JP, Snyder SH. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci USA. 1994;91:3191-5   DOI   ScienceOn
32 Miyata K, Omori N, Uchino H, Yamaguchi T, Isshiki A, Shibasaki F. Involvement of the brainderived neurotrophic factor/TrkB pathway in neuroprotective effect of cyclosporin A in forebrain ischemia. Neuroscience. 2001;105:571-8   DOI   ScienceOn
33 Roobol A, Holmes FE, Hayes NV, Baines AJ, Carden MJ. Cytoplasmic chaperonin complexes enter neurites developing in vitro and differ in subunit composition within single cells. J Cell Sci. 1995;108:1477-88   PUBMED